• 1
    Adams, J.M. & Cory, S. (1998) The Bcl-2 protein family: arbiters of cell survival. Science, 281, 132213226.
  • 2
    Aricò, M., Janka, G., Fischer, A., Henter, J.-I., Blanche, S., Elinder, G., Martinetti, M. & Rusca, M.P. (1996) Hemophagocytic lymphohistiocytosis: report of 122 children from the international registry. Leukemia, 10, 197203.
  • 3
    Ashkenazi, A. & Dixit, V.M. (1998) Death receptors: signaling and modulation. Science, 281, 13051308.
  • 4
    Bettinardi, A., Brugnoni, D., Quiròs-Roldan, E., Malagoli, A., La Grutta, S., Correra, A. & Notarangelo, L.D. (1997) Missense mutations in the Fas gene resulting in autoimmune lymphoproliferative syndrome: a molecular and immunological analysis. Blood, 89, 902909.
  • 5
    Brunetti, M., Martelli, N., Colasante, A., Piantelli, M., Musiani, P. & Aiello, F.B. (1995) Spontaneous and glucocorticoid-induced apoptosis in human mature T lymphocytes. Blood, 86, 41994205.
  • 6
    Cheng, E.H-Y., Kirsch, D.G., Clem, R.J., Ravi, R., Kastan, M.B., Bedi, A., Ueno, K., & Hardwick, J.M. (1997) Conversion of bcl-2 to a bax-like death effector by caspases. Science, 278, 19661968.
  • 7
    Clerici, M., Sarin, A., Coffman, R.L., Wynn, T.A., Blatt, S.P., Hendrix, C.W., Wolf, S.F., Shearer, G.M. & Henkart, P.A. (1994) Type 1/type 2 cytokine modulation of T-cell programmed cell death as a model for human immunodeficiency virus pathogenesis. Proceedings of the National Academy of Sciences of the United States of America, 91, 1181111815.
  • 8
    Déas, O., Dumont, C., MacFarlane, M., Rouleau, M., Hebib, C., Harper, F., Hirsch, F., Charpentier, B., Cohen, G.M. & Senik, A. (1998) Caspase-independent cell death induced by anti-CD2 or staurosporine in activated human peripheral T lymphocytes. Journal of Immunology, 161, 33753383.
  • 9
    Drappa, J., Vaishnaw, A.K., Sullivan, K.E., Chu, J.-L. & Elkon, K.B. (1996) Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity. New England Journal of Medicine, 335, 16431649.
  • 10
    Egeler, R.M., Shapiro, R., Loechelt, B. & Filipovich, A. (1996) Characteristic immune abnormalities in hemophagocytic lymphohistiocytosis. Journal of Pediatric Hematology/Oncology, 18, 340345.
  • 11
    Fadeel, B., Åhlin, A., Henter, J.-I., Orrenius, S. & Hampton, M.B. (1998) Involvement of caspases in neutrophil apoptosis: regulation by reactive oxygen species. Blood, 92, 48084818.
  • 12
    Fadeel, B., Hassan, Z., Hellström-Lindberg, E., Henter, J.-I., Orrenius, S. & Zhivotovsky, B. (1999) Cleavage of Bcl-2 is an early event in chemotherapy-induced apoptosis of human myeloid leukemia cells. Leukemia, 13, 719728.
  • 13
    Farquhar, J.W. & Claireaux, A.E. (1952) Familial hemophagocytic reticulosis. Archives of Disease in Childhood, 27, 519525.
  • 14
    Fisher, G.H., Rosenberg, F.J., Straus, S.E., Dale, J.K., Middleton, L.A., Lin, A.Y., Strober, W., Lenardo, M.J. & Puck, J.M. (1995) Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell, 81, 935946.
  • 15
    Friesen, C., Herr, I., Krammer, P.H. & Debatin, K.-M. (1996) Involvement of the CD95(APO-1/Fas) receptor/ligand system in drug-induced apoptosis in leukaemia cells. Nature Medicine, 2, 574577.
  • 16
    Gencik, A., Signer, E. & Müller, H. (1984) Genetic analysis of familial erythrophagocytic lymphohistiocytosis. European Journal of Pediatrics, 142, 248252.
  • 17
    Grandgirard, D., Studer, E., Monney, L., Belser, T., Fellay, I., Borner, C. & Michel, M.R. (1998) Alphaviruses induce apoptosis in Bcl-2-overexpressing cells: evidence for a caspase-mediated, proteolytic inactivation of Bcl.-2. EMBO Journal, 17, 12681278.
  • 18
    Haddad, E., Sulis, M.-L., Jabado, N., Blanche, S., Fischer, A. & Tardieu, M. (1997) Frequency and severity of central nervous system lesions in hemophagocytic lymphohistiocytosis. Blood, 89, 794800.
  • 19
    Hasegawa, D., Kojima, S., Tatsumi, E., Hayakawa, A., Kosaka, Y., Nakamura, H., Sako, M., Osugi, Y., Nagata, S. & Sano, K. (1998) Elevation of the serum Fas ligand in patients with hemophagocytic syndrome and Diamond-Blackfan anemia. Blood, 91, 27932799.
  • 20
    Henter, J.-I., Andersson, B., Elinder, G., Jakobson, Å., Lübeck, P.-O. & Söder, O. (1996) Elevated circulating levels of interleukin-1 receptor antagonist but not IL-1 agonists in hemophagocytic lymphohistiocytosis. Medical and Pediatric Oncology, 27, 2125.
  • 21
    Henter, J.-I., Aricò, M., Egeler, M., Elinder, G., Favara, B.E., Filipovich, A.H., Gadner, H., Imashuku, S., Janka-Schaub, G., Komp, D., Ladisch, S. & Webb, D. (1997) HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. Medical and Pediatric Oncology, 28, 342347.
  • 22
    Henter, J.-I., Aricò, M., Elinder, G., Imashuku, S. & Janka, G. (1998) Familial hemophagocytic lymphohistiocytosis: primary hemophagocytic lymphohistiocytosis. Hematology/Oncology Clinics of North America, 12, 417433.
  • 23
    Henter, J.-I., Elinder, G., Öst, Å. (1991a) Diagnostic guidelines for hemophagocytic lymphohistiocytosis. Seminars in Oncology, 18, 2933.
  • 24
    Henter, J.-I., Elinder, G., Söder, O., Hansson, M., Andersson, B. & Andersson, U. (1991b) Hypercytokinemia in familial hemophagocytic lymphohistiocytosis. Blood, 78, 2918.
  • 25
    Henter, J.-I. & Nennesmo, I. (1997) Neuropathologic findings and neurologic symptoms in twenty-three children with hemophagocytic lymphohistiocytosis. Journal of Pediatrics, 130, 358365.
  • 26
    Imashuku, S., Ikushima, S., Esumi, N., Todo, S. & Saito, M. (1991) Serum levels of interferon-gamma, cytotoxic factor and soluble interleukin-2 receptor in childhood hemophagocytic syndrome. Leukemia and Lymphoma, 3, 287292.
  • 27
    Iwai, K., Miyawaki, T., Takizawa, T., Konno, A., Ohta, K., Yachie, A., Seki, H. & Taniguchi, N. (1994) Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils. Blood, 84, 12011208.
  • 28
    Janka, G., Imashuku, S., Elinder, G., Schneider, M. & Henter, J.-I. (1998) Infection- and malignancy-associated hemophagocytic syndromes: secondary hemophagocytic syndromes. Hematology/Oncology Clinics of North America, 12, 435444.
  • 29
    Janka, G.E. (1983) Familial hemophagocytic lymphohistiocytosis. European Journal of Pediatrics, 140, 221230.
  • 30
    Komp, D.M., McNamara, J. & Buckley, P. (1989) Elevated soluble interleukin-2 receptor in childhood hemophagocytic histiocytic syndromes. Blood, 73, 21282132.
  • 31
    Ladisch, S., Poplack, D.G., Holiman, B. & Blaese, R.M. (1978) Immunodeficiency in familial erythrophagocytic lymphohistiocytosis. Lancet, i, 581583.
  • 32
    Lemaire, C., Andréau, K., Souvannavong, V. & Adam, A. (1998) Inhibition of caspase activity induces a switch from apoptosis to necrosis. FEBS Letters, 425, 266270.
  • 33
    Liu, C.-C., Young, L.H.Y. & Young, J.D.-E. (1996) Lymphocyte-mediated cytolysis and disease. New England Journal of Medicine, 335, 16511658.
  • 34
    Nagata, S. (1997) Apoptosis by death factor. Cell, 88, 355365.
  • 35
    Nicholson, D.W., Ali, A., Thornberry, N.A., Vaillancourt, J.P., Ding, C.K., Gallant, M., Gareau, Y., Griffin, P.R., Labelle, M., Lazebnik, Y.A., Munday, N.A., Raju, S.M., Smulson, M.E., Yamin, T.-T., Yu, V.L. & Miller, D.K. (1995) Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature, 376, 3743.
  • 36
    Rieux-Laucat, F., Le Deist, F., Hivroz, C., Roberts, I.A.G., Debatin, K.-M., Fischer, A. & De Villartay, J.P. (1995) Mutations in Fas associated with human lymphoproliferative syndrome. Science, 268, 13471349.
  • 37
    Samali, A., Zhivotovsky, B., Jones, D.P. & Orrenius, S. (1998) Detection of pro-caspase-3 in cytosol and mitochondria of various tissues. FEBS Letters, 431, 167169.
  • 38
    Scheipers, P. & Reiser, H. (1998) Fas-independent death of activated CD4+ T lymphocytes induced by CTLA-4 crosslinking. Proceedings of the National Academy of Sciences of the United States of America, 95, 1008310088.
  • 39
    Schneider, P., Holler, N., Bodmer, J.-L., Hahne, M., Frei, K., Fontana, A. & Tschopp, J. (1998) Conversion of membrane-bound Fas (CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. Journal of Experimental Medicine, 187, 12051213.
  • 40
    Suda, T., Hashimoto, H., Tanaka, M., Ochi, T. & Nagata, S. (1997) Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing. Journal of Experimental Medicine, 186, 20452050.
  • 41
    Thornberry, N.A. & Lazebnik, Y. (1998) Caspases: enemies within. Science, 281, 13121316.
  • 42
    Tivol, E.A., Borriello, F., Schweitzer, A.N., Lynch, W.P., Bluestone, J.A. & Sharpe, A.H. (1995) Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity, 3, 541547.
  • 43
    Zhivotovsky, B., Burgess, D.H., Vanags, D.M. & Orrenius, S. (1997) Involvement of cellular proteolytic machinery in apoptosis. Biochemical and Biophysical Research Communications, 230, 481488.